TM
Thomas S McHugh
Chief Financial Officer

Thomas S McHugh insider trades: Avadel Pharmaceuticals (AVDL) stock buys and sales

Chief Financial Officer, Avadel Pharmaceuticals Last trade Dec 13, 2024 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 13, 2024AVDL↑ Buy$24K
Dec 11, 2024AVDL↑ Buy$52K
Jan 16, 2024AVDL↑ Buy$29K
Aug 14, 2023AVDL↑ Buy$29K
Nov 29, 2022AVDL↑ Buy$39K
May 27, 2022AVDL↑ Buy$107K
Sep 18, 2020AVDL↑ Buy$24K
Aug 28, 2020AVDL↑ Buy$51K
Aug 13, 2020AVDL↑ Buy$78K
May 4, 2005HBP↓ Sell$137K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AVDL insiders

Open-market trades in the last 12 months

About Thomas S McHugh's insider trades

Thomas S McHugh is Chief Financial Officer at Avadel Pharmaceuticals (AVDL). Since May 4, 2005, Thomas has reported 9 open-market purchases worth $433K and 1 sale worth $137K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVDL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.